Company: NDRA
Filing Date: 2025-05-30
Form Type: 8-K
Source: 0001654954-25-006282
Chunk: 1

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-05-30
Form: 8-K
Item: Item 3.01
Chunk 1
---
 appealing any delisting determination.

Cautionary Note regarding Forward-Looking Statements

All statements in this Current Report on Form 8-K that are not based on historical fact are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “will” and other comparable terms. Examples of forward-looking statements include, among others, statements regarding the Company’s ability to regain compliance with Nasdaq rules and expectations regarding the outcome of any potential hearing before an independent panel. The forward-looking statements made in this report speak only as of the date of this report, and the Company assumes no obligation to update any such forward-looking statements to reflect actual results or changes in expectations, except as otherwise required by law.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  ENDRA Life Sciences Inc.                               
  May 30, 2025                                           
  By:                           /s/ Richard Jacroux      
  Name:                         Richard Jacroux          
  Title:                        Chief Financial Officer  

   3